What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review Read More > February 11, 2021
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings Read More > February 10, 2021
Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects Read More > February 3, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research Read More > February 3, 2021
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Read More > February 2, 2021
Increased sensitivity to strong perturbations in a whole-brain model of LSD Read More > January 29, 2021
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine Read More > January 25, 2021
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression Read More > January 22, 2021
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression Read More > January 22, 2021
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants Read More > January 20, 2021
